Envoy Medical, Inc. (COCH)
0.6512
0.00 (0.00%)
USD |
NASDAQ |
Oct 08, 16:00
0.6512
0.00 (0.00%)
After-Hours: 18:22
Envoy Medical Max Drawdown (5Y) : 96.29% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.29% |
| August 31, 2026 | 96.29% |
| July 31, 2026 | 96.29% |
| June 30, 2026 | 96.29% |
| May 31, 2026 | 96.29% |
| April 30, 2026 | 96.29% |
| March 31, 2026 | 96.29% |
| February 28, 2026 | 96.29% |
| January 31, 2026 | 93.81% |
| Date | Value |
|---|---|
| December 31, 2025 | 93.79% |
| November 30, 2025 | 93.79% |
| October 31, 2025 | 92.87% |
| September 30, 2025 | 92.61% |
| August 31, 2025 | 91.33% |
| July 31, 2025 | 91.33% |
| June 30, 2025 | 91.33% |
| May 31, 2025 | 91.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Electromed, Inc. | 52.65% |
| Accuray, Inc. | 96.34% |
| Micron Solutions, Inc. | 100.0% |
| IDEXX Laboratories, Inc. | 54.00% |
| Neogen Corp. | 90.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.68 |
| Beta (5Y) | 1.966 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 189.9% |
| Historical Sharpe Ratio (5Y) | -0.2371 |
| Historical Sortino (5Y) | -0.6705 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.44% |